Unveiling Platelet Function and Disease Value: The Pivotal Role of Mouse CD42b Antibodies by ANT BIO PTE. LTD.

1. Concept

Platelets are critical cellular players not only in hemostasis and thrombosis but also in immune regulation, inflammatory responses, angiogenesis, and tumor progression. Their diverse functions are mediated by surface membrane glycoproteins, with the glycoprotein Ib-IX-V complex—comprising CD42a and CD42b (GP1bα) subunits—being central to platelet adhesion. CD42b enables platelets to bind von Willebrand factor (vWF) on the subendothelial matrix, a key step in maintaining platelet adhesion under high shear stress. Mouse CD42b antibodies serve as essential tools for specifically identifying platelets, analyzing their functional states, and exploring their roles in physiological and pathological processes, bridging basic research and preclinical translation.

2. Research Frontiers

A key research frontier focuses on deciphering the crosstalk between platelets, inflammation, and immunity using CD42b as a molecular tool. Studies are exploring how CD42b-mediated platelet adhesion influences leukocyte recruitment and cytokine release, shedding light on the role of platelets in chronic inflammatory diseases such as atherosclerosis and autoimmune disorders.

Another active area of investigation involves optimizing antiplatelet therapies by targeting CD42b. Researchers are developing novel agents that block the CD42b-vWF interaction to prevent thrombosis while minimizing bleeding risks, with mouse CD42b antibodies critical for preclinical efficacy and safety evaluation.

Emerging frontiers also include exploring CD42b’s role in tumor progression and metastasis. Platelets promote tumor angiogenesis and immune evasion, and studies are using CD42b antibodies to dissect the underlying mechanisms, potentially identifying new therapeutic targets for cancer.

3. Research Significance

Investigating CD42b and leveraging mouse CD42b antibodies holds profound significance for both basic science and clinical practice. In basic research, these antibodies enable precise characterization of platelet function, advancing our understanding of platelet biology in hemostasis, inflammation, and disease. This knowledge forms the foundation for developing targeted therapies.

Clinically, CD42b is a key diagnostic marker for platelet disorders (e.g., Bernard-Soulier syndrome, caused by CD42b defects) and a prognostic indicator for thrombotic diseases. Mouse CD42b antibodies support preclinical development of antiplatelet drugs, helping evaluate efficacy and guide personalized treatment. Additionally, their use in disease models accelerates the translation of experimental findings to clinical applications, benefiting patients with thrombotic, bleeding, or inflammatory disorders.

4. Related Mechanisms, Research Methods, and Product Applications

Related Mechanisms

Platelet function is governed by membrane glycoprotein-mediated interactions. As illustrated in the diagram, the glycoprotein Ib-IX-V complex (CD42a/CD42b) mediates initial platelet adhesion to vWF at sites of vascular injury, even under high shear stress. Upon activation, platelets expose P-selectin (CD62P) and activate the glycoprotein IIb/IIIa (CD41/CD61) complex, which binds fibrinogen to mediate platelet aggregation. CD42b is essential for the early adhesion step, making it a critical target for studying thrombosis and bleeding disorders.

Research Methods and Product Applications

Mouse CD42b antibodies are versatile tools supporting diverse research and preclinical applications. ANT BIO PTE. LTD.’s PerCP-Cy5.5 Mouse Anti-Human CD42b Antibody (Catalog No.: S0B1729) stands out for its high specificity, superior fluorescence performance, and multi-platform compatibility, making it an essential reagent for platelet research and drug development.

Key Applications of the Antibody:

• Platelet Identification and Functional Analysis: In flow cytometry, the antibody specifically gates mouse platelet populations, distinguishing them from other blood cells. Combined with activation markers (e.g., CD62P), it assesses platelet activation status in thrombosis, inflammation, or tumor models.
• Functional Blockade Studies: In vitro or in vivo blockade of CD42b with the antibody elucidates the role of the glycoprotein Ib-IX-V complex in hemostasis, thrombosis, and inflammation, validating CD42b as a therapeutic target.
• Disease Model Validation: In mouse models of platelet disorders (e.g., Bernard-Soulier syndrome) or thrombotic diseases, the antibody confirms phenotypic features (e.g., adhesion defects) and evaluates functional recovery post-intervention.
• Antiplatelet Drug Evaluation: The antibody monitors platelet activation in preclinical studies of antiplatelet agents (e.g., aspirin, clopidogrel), assessing drug efficacy by measuring changes in CD42b expression and platelet adhesion.
• Multicolor Flow Cytometry: The PerCP-Cy5.5 conjugate integrates seamlessly with other fluorochromes (e.g., FITC, PE, APC), enabling simultaneous detection of multiple platelet markers for comprehensive functional analysis.

Core Advantages of the Antibody:

• Superior Fluorescence Performance: The PerCP-Cy5.5 label emits at ~695 nm, offering high brightness, photostability, and minimal spectral overlap with common fluorochromes. This ensures clear platelet population discrimination in complex multicolor flow panels.
• Exceptional Specificity: The antibody specifically targets CD42b (GP1bα) on resting and activated platelets, enabling precise identification and gating in heterogeneous blood samples, with minimal cross-reactivity to other cell types.
• Ready-to-Use Convenience and Batch Consistency: Pre-titrated and provided in a ready-to-use buffer, the antibody simplifies experiments. Rigorous quality control ensures consistent fluorescence intensity and specificity across batches, guaranteeing reproducible results.

Clinical Applications of Platelet Membrane Glycoprotein Testing:

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to advancing life science research and clinical diagnostics by providing high-performance, high-value core reagents and comprehensive solutions. Leveraging advanced development platforms—including recombinant rabbit monoclonal antibody, recombinant mouse monoclonal antibody, rapid mouse monoclonal antibody, and recombinant protein development platforms (E.coli, CHO, HEK293, Insect Cells), as well as the One-Step ELISA Platform and PTM Pan-Modification Antibody Platform—the company adheres to stringent quality standards and has successfully obtained EU 98/79/EC certification, ISO9001 certification, and ISO13485 certification. ANT BIO PTE. LTD. strives to support researchers and clinicians worldwide in their pursuit of scientific breakthroughs, improved patient care, and the development of innovative therapies for thrombotic, bleeding, and inflammatory diseases.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.